Register and share your invite link to earn from video plays and referrals.

Search results for 13:ACE
13:ACE community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including 13:ACE
⚡️A 9B embodied AI model beats GPT-6 Astra on 6 of 8 spatial grounding benchmarks. ACE Robotics' ACE-Brain-0.6 is fine-tuned from Qwen3.5-9B using ~1M spatial grounding samples with verifiable visual evidence. > 74.53 average across 7 public benchmarks, vs. 73.68 for Astra > 94.13 on ACE’s RobotGrounding benchmark, vs. 91.10 for Astra Beyond locating objects, the model can identify when a target is missing — a critical capability for robots that need to know when NOT to act. The data scaling results are just as interesting: > expanding training data from 260K to ~1M samples raised the average score from 69.3 to 74.5. > Simply adding more of the same data types improved scores by less than 1 point. New scenes, spatial relationships and diverse supervision drove the bigger gains.
Show more
I've ripped Omarchy off an old Acer and I'm replacing it with a lightweight Debian 13 setup. The plan is to use it almost exclusively for X Pro. I've somehow ended up installing an entire operating system so I can watch people argue about software 😂 (I know I could have just bought another screen...😆)
Show more
Ace Combat 8: Wings of Theve has the highest Steam peak in the series, according to SteamDB. The tracker shows an all-time peak of 48,743 players, hit 14 hours ago. 42,612 were still in-game on the same chart. Ace Combat 7: Skies Unknown peaked at 13,758 at its February 2019 launch, on that same tracker. The full release is out on Steam, PS5, and Xbox Series X/S. The count is a Steam peak, not total sales.
Show more
Now that is how you ACE an uphill sprint! 🥵⚡ Relive the winning moment from Stage 2 of the Czech Tour 2025! The 2026 edition is on SBS tonight from 11.00PM AEST! 🤩 🇨🇿 Czech Tour | August 13-16 | SBS On Demand 📺
Show more
S3 | #PSUVB# 25, OSU 11 🦁 K-Mart - 13 kills, .333, 10 digs, 3 aces 🦁 Stucky - 33 assists, 12 digs, 2 aces 🦁 Lauenstein - 8 kills, 4 digs, 4 blocks #WeAre#
Always love beating the Buckeyes 🙌 🦁 K-Mart - 18 kills, .368, 13 digs, 4 aces 🦁 Stucky - 47 assists, 15 digs, 5 kills 🦁 Nichols - 9 blocks, 6 kills, 1 ace #WeAre#
NO. 24 BYU OPENS HOME SLATE WITH EASTERN ILLINOIS, NO. 2 PITT PROVO, Utah — No. 24 BYU women's volleyball hosts its first two home matches of the season this week. The Cougars will welcome Eastern Illinois and No. 2 Pittsburgh to the Smith Fieldhouse for a pair of matches Thursday and Friday. BYU remained at No. 24 in this week's American Volleyball Coaches Association (AVCA) poll after picking up a pair of wins at the FGCU Invitational in Fort Myers, Florida, last week, overcoming a 2-0 deficit to reverse sweep Florida State before beating host Florida Gulf Coast in four sets. Following the weekend's matches, opposite hitter Sophia Callahan was named the tournament MVP, while setter Alex Bower was honored as a member of the all-tournament team. Callahan's 19 kills came on a .325 hitting percentage, while Bower posted 44 assists and 12 digs. Callahan added seven digs and four blocks. Bower and fellow setter Kaylie Kofe (45 assists) spread the Cougar offense around as seven different hitters recorded a kill in the tournament: Claire Little Chambers (21), Callahan (19), Kate Prior (16), Brooke Hardy (15, .393 hitting percentage), Elli Mortensen (14), Kelli Jo Burgess (13, .478 hitting percentage) and Dimitra Nanou(nine). Burgess led the way defensively with 16 total blocks, averaging 1.78 per set, while Little Chambers contributed 11 (1.22 per set). Hardy tallied seven, while Prior posted five. Through two matches, BYU is hitting .269 as a team while holding opponents to a .212 hitting percentage. The Cougars are averaging 12 kills per set, 11.22 assists per set, 9.22 digs per set, 2.61 blocks per set and 1.56 aces per set. Individually, Mortensen's 0.83 aces per set rank 20th nationally and third in the Big 12. Burgess' 1.78 blocks per set rank 23rd nationally and fifth in the Big 12. Beginning a stretch of four of the next five matches at home, the Cougars will square off with a set of Panthers, opening with the first-ever meeting against Eastern Illinois before their first Top 25 matchup of the season against No. 2 Pitt. Up Next BYU will head back out on the road for a Tuesday night match at Boise State before returning home to host UCLA later in the week. Full details: 📸: @BYUwvolleyball @BYUphoto
Show more
In July I published an article on @ZetaGlobal $ZETA arguing that the $PLTR partnership should accelerate their forward growth. Shares were $21.05 that morning and today the name trades around $33 which is more than a double off the spring lows while being up roughly 57% since that article. The question that I keep getting asked is whether or not I still believe ZETA is undervalued. My thesis is that ZETA crossed the inflection point in profitability in Q2 and a market cap of roughly $8.3 billion still does not reflect what the next several years should look like. Below I walk through the Q2 print, what management said at the recent $GS and $C conferences in September and why I think ZETA is still cheap for what is coming. Q2 was the quarter the profitability inflection showed up in the numbers On August 4th ZETA reported its Q2 2026 results and delivered its 20th consecutive beat and raise quarter. They generated $443 million in revenue grew 44% YoY and exceeded the midpoint of guidance by $23 million while organic growth excluding M&A was 28%. Adjusted EBITDA increased 56% YoY to $91.7 million as their adjusted EBITDA margin expanded 170 bps to 20.7% which puts ZETA at the Rule of 64. The number I cared most about was GAAP net income of $8.2 million and GAAP EPS of $0.03 compared to a net loss of $12.8 million a year ago. Cash from operations grew 65% YoY to $69.2 million and free cash flow ((FCF)) grew 73% YoY to $58 million at a 13.1% FCF margin. Management raised full-year revenue guidance by $33 million to $1.818 billion at the midpoint which is 39% YoY growth and raised FCF guidance to $255.3 million which is 55% YoY growth. GAAP EPS guidance more than tripled to a range of $0.09 to $0.11 which makes 2026 the first GAAP-profitable fiscal year in ZETA’s history. The trailing twelve month ((TTM)) numbers show how far ZETA has come. TTM operating income bottomed at a loss of $316 million in Q1 2022 and reached positive $30 million through Q2 2026 compared to a loss of $15 million a year earlier. TTM revenue went from $368 million at the end of 2020 to $1.57 billion which is a 30.2% CAGR and the losses stopped before the growth rate did. The cash flow side moved even faster as TTM operating cash flow went from $36 million at the end of 2020 to $241 million while TTM FCF went from $10 million to $224 million which is a 75% CAGR. ZETA generated $69.2 million of operating cash flow in Q2 and put $29.9 million of it into buybacks and finished the quarter with $310 million of cash against $197.5 million of debt. The business is running ahead of its own model Management publishes a long-term model so there is no guessing about which metrics matter. The model calls for adding 4% to 8% more customers annually while ZETA has been averaging 15%. It calls for net revenue retention ((NRR)) of 110% to 115% which is currnetly being exceeded as NRR has come in at 112%, 114% and 120% over the last three years. Super-scaled customers grew 17% YoY to 197 and super-scaled customer ARPU grew 17% YoY to $1.8 million which are both ahead of the Zeta 2028 model. Chris Greiner walked through the cohort data at Citi. A pilot starts around $100,000 and customers spend roughly $700,000 in their first 12 months. That grows to $1.1 million in years 1 to 3 then $2.1 million in years 3 to 5 and $3.9 million once a customer passes 5 years. The sales pipeline was up 40% YoY in Q1 and accelerated to 60% YoY in Q2 before counting a single Palantir opportunity and deals closed in Q2 were 40% larger than a year ago. ZETA grew revenue 44% while growing quota carriers 11% which tells me productivity is doing the heavy lifting. Athena is the piece I believe the market is still underestimating. Athena went generally available in March and within four months 40% of super-scaled customers were monthly active users with 83% of that engagement coming through voice. Customers who adopted ZOE spent 250% more than customers who did not and ZOE was a rudimentary navigation tool. Palantir is still not in the numbers ZETA moved the Data Cloud off AWS and re-architected it on top of Foundry. The 7-year agreement carries escalating incentives tied to client wins and contract value. @dsteinberg10000 said at Goldman that the $100 million per year figure now seems very low compared to what they are seeing and he has personally gone into 3 meetings with Palantir and come out with 3 yeses. ZETA has ring-fenced 20 opportunities with Palantir’s largest customers which are brands spending over $1 billion per year on marketing and these pilots are emerging at roughly 10x the size of a normal $50,000 to $150,000 pilot. When I wrote about ZETA in July the guidance assumed nothing from Palantir and management still guides with 2 to 5 points of conservatism baked in. Zeta Live is on October 8th and Steinberg said they will make the three biggest announcements in company history around Athena helping enterprises run their entire businesses rather than just their marketing. ZETA announced two acquisitions this week and both extend the Data Cloud On October 5th ZETA announced an agreement to acquire Senso which is a Y Combinator-backed AI engineering company whose technology already helps power ZETA’s generative engine optimization ((GEO)) product. GEO is the business that helps brands show up in the answers coming out of ChatGPT, Gemini, Claude and Google AI Overviews and Steinberg said at Goldman that he thinks GEO becomes the next SEO. The part he cares about more is the data as ZETA is now extracting more signal from GEO than from the bottom 2 million of the 5.2 million publishers in its network. Senso brings that technology in-house along with the engineering team and deeper connectivity to the frontier models and it plugs directly into the OpenAI relationship. What may be overlooked is that ZETA is already serving ads inside ChatGPT and pulling signal back through the API. I am excited for Saroop Bharwani speaking at Zeta Live tomorrow. Yesterday ZETA followed up with an agreement to acquire Digital Audience which is a data infrastructure company that was already integrated with the platform and expands identity resolution and activation across every channel. Identity is the moat and activation is where the consumption meter runs so this deal reinforces both sides of the revenue model at once. The deal with Digital Audience also strengthens ZETA’s European presence and brings established enterprise relationships in the region. This allows them to fortify the international identity graph. While the details were not disclosed ZETA has $310 million of cash and closed a new $1 billion credit facility in July so neither deal should stress the balance sheet. The best part is that Steinberg said both are separate from whatever gets announced at Zeta Live. Why I think ZETA is still cheap under $10 billion ZETA has a market cap of roughly $8.3 billion and trades at about 32x the midpoint of their 2026 FCF guidance while trading at about 20x 2026 adjusted EBITDA on an enterprise value basis. The multiple expanded as ZETA traded at 23x FCF in July while FCF guidance only moved from $235 million to $255 million. Analysts have 2026 revenue at $1.82 billion growing 39.5% then 2027 revenue at $2.11 billion growing 16% and 2028 revenue at $2.42 billion growing 14.5%. The consensus adjusted EPS for 2026 is $0.97 and $1.43 for 2028 which puts ZETA at 34x this year’s earnings and 23x 2028 earnings. I think the 2027 and 2028 numbers are too low. ZETA grew organically at 28% last quarter and NRR alone has been running at 115% to 120% before a single new deal is inked and let's not forget how impactful the deal with Palantir is expected to be. If ZETA grows 24% in 2027 then revenue lands at $2.25 billion instead of $2.11 billion and the EPS estimates have to move with it. Using management’s 2030 target of a 20% FCF margin on the consensus 2030 revenue estimate of $2.82 billion gets you $564 million of FCF which means ZETA trades at under 15x 2030 FCF today. That consensus number assumes growth decelerates to 4.6% by 2030. Mr. Market priced ZETA like a 15% grower in January when it was growing organically at 29% and I think the same mistake is being made on a forward basis. Conclusion I built a position in ZETA because growth was accelerating and margins were expanding at a price that did not reflect it. The stock doubled and every pillar of the thesis is stronger than it was. Revenue growth accelerated to 44% and ZETA turned GAAP profitable while running ahead of every metric in their long-term model. Palantir, Athena consumption, Snowflake and the two acquisitions announced this week are still not in the guidance. At $8.3 billion ZETA trades at under 15x what management’s own 2030 margin target implies on a consensus revenue number I think is too low. I'm still very bullish on ZETA and I can't wait for ZETA Live tomorrow because I believe @dsteinberg10000 is holding aces. @amitisinvesting and I had the opportunity to interview David on @basispointpod and I would highly recommend listening to how passionate he is about the future for ZETA. David Steinberg, CEO of Zeta | Basis Points via @YouTube
Show more
I am the Health Services Contract Administrator for U.S. Immigration and Customs Enforcement and on October 3, 2025, I stopped paying for medical care, and the system has been working better ever since. I need to be specific about what "working better" means in this context because I am a contract administrator and specificity is my entire professional identity. It means: fewer invoices. Fewer reimbursement disputes. Fewer pharmacy reconciliations. Fewer appeals from providers who claim they provided urgent care and want to be compensated for having provided it. The workflow is cleaner. My inbox is lighter. The VA Financial Services Center, which had processed our medical claims since 2002, twenty-two years of pharmacy invoices, specialist referrals, hospital transports, dialysis authorizations, and oncology treatment plans, terminated its interagency agreement with us after a lawsuit from a nonprofit called the Center to Advance Security in America. They filed suit. The VA pulled out. Our entire claims processing pipeline vanished overnight. I posted a notice on on November 12 describing this as an "absolute emergency" that required resolution "immediately" to "prevent any further medical complications or loss of life." That was seven months ago. The replacement contractor, Acentra Health, had not achieved notice to proceed by the April 30 period of performance deadline. As of today, no entity is processing medical reimbursement claims for ICE detainees in the United States. When I say "no entity" I mean that structurally. A person held in a GEO Group facility in Georgia who requires dialysis three times per week is receiving dialysis from a provider who has not been paid since October. The provider continues to provide care because the alternative is that the confined person dies in their facility and the facility is then liable for a death that could have been prevented by a treatment that the facility was contractually obligated to provide. The treatment continues. The payment does not. The provider absorbs the cost. The cost is eventually written off. The write-off appears in the provider's quarterly financial statements as "uncompensated care, federal detention." It does not appear in our budget. It does not appear in any ICE financial disclosure. The care happened. The cost was real. The payment was imaginary. The system is working better. In fiscal year 2024, the VA processed $246.42 million in clinical reimbursement claims on our behalf. In fiscal year 2025, despite an 82.5% increase in our daily detained headcount, the VA processed only $157.2 million before the October termination. The delta between what was needed and what was processed is approximately $300 million. That $300 million represents medications not reimbursed, specialist consultations not paid for, emergency transports not covered, prenatal visits not compensated. It represents chemotherapy sessions where the drugs were administered and the oncologist submitted an invoice and the invoice entered a system that no longer exists. I have a filing cabinet in my office — three drawers, GSA-standard, beige, the kind with the lock that everyone has the same key to — that contains printed copies of the final VA-processed claims from September 2025. The bottom drawer has a jar of Tums that my predecessor left when she transferred to FEMA in August. I eat them daily. Not from stress. From the cafeteria. The cafeteria serves a chili that the facilities contractor, Aramark, describes as "Southwestern-inspired." It is inspired by the Southwest the way our medical payment system is inspired by the concept of paying for medical care. The death rate is the number people ask about, so I will provide it with the precision my role requires. Historical baseline, 2018 through 2024: 8.9 deaths per year in ICE custody. Calendar year 2025: 33 deaths. Twelve of those occurred after October 3, after the payment freeze. January through April 2026: 17 deaths. That is one death every six days. Annualized, the current rate is 51.7 deaths per year. 5.8 times the pre-October baseline. A study published in JAMA on April 16 calculated the per-capita rate: 88.9 deaths per 100,000 person-years in partial fiscal 2026, compared to 13.0 in fiscal 2023. Nearly seven times. The JAMA authors are epidemiologists. I am a contract administrator. We are counting the same bodies with different denominators. Emmanuel Damas was 56 years old, Haitian, confined at an installation I am not authorized to name. He had a tooth infection. The on-call clinical staff treated the infection with ibuprofen. Ibuprofen is an anti-inflammatory. A tooth infection is a bacterial event. These are different categories of medical problem requiring different categories of intervention. The infection progressed to septic shock. Emmanuel Damas died. The ibuprofen was on our formulary. Antibiotics were on our formulary. The difference between the two was a reimbursement claim that would have been submitted to a payment processor that no longer existed. The detention center chose the treatment that did not generate a claim. I cannot tell you whether that decision was made consciously. I can tell you that it was made consistently. Across multiple facilities. Across multiple months. The ACLU reviewed deaths in ICE detention between 2017 and 2021, before the payment freeze, and determined that 95% were preventable with adequate treatment. I do not know what the percentage is now. I suspect it is also 95%. The category "preventable" has not changed. The category "payment" has. At Fort Bliss, a military installation in El Paso repurposed as a detention facility under a $1.24 billion sole-source contract awarded to Acquisition Logistics, a firm with no prior detention management experience, three people died within 44 days. One death was ruled a homicide by the El Paso County Medical Examiner. ICE reported it as a suicide. Those are different words describing different events with different legal implications. The Medical Examiner's ruling generates an investigation. A suicide generates a compliance review. An investigation involves law enforcement. A compliance review involves my filing cabinet. I am not qualified to determine which word is correct. I am qualified to tell you that the words produce different paperwork, and the paperwork determines which systems activate, and the systems that activate determine who is accountable, and in this case, the system that activated was the compliance review, and the compliance review found that all protocols were followed, and all protocols were followed because the protocols do not include "pay for medical care." Rodney Taylor was a double amputee detained at Stewart Detention Center, operated by CoreCivic. He was forced to crawl on floors covered in feces and mold because the center did not provide adequate mobility assistance. CoreCivic reported $2.2 billion in revenue last year, up 13%. Their profit was $116.5 million, up 70% year over year. Their ICE revenue nearly doubled between Q4 2024 and Q4 2025, from $120 million to $245 million per quarter. They received a 70% increase in profit and Rodney Taylor received a floor. CoreCivic's annual report describes their business model as "government solutions." Rodney Taylor's experience was, technically, a government solution. GEO Group, the other major for-profit detention operator, posted $2.6 billion in revenue in 2025 and $254 million in profit, a 700% increase. They secured $520 million in new ICE task orders that year. Combined, GEO and CoreCivic spent $6.8 million on lobbying to secure access to a $75 billion funding stream from the GOP's reconciliation bill. The return on that investment is so large I had to check my calculator twice. It was not a calculator error. It was the normal functioning of a procurement system where the companies that run the facilities also fund the campaigns of the legislators who appropriate the money for the facilities. The firm-fixed-price task orders specify a per diem rate of $187.48 per adult per day. That rate includes healthcare coverage. The rate has not changed since the disbursement freeze. We are still remitting $187.48 per day per person. The clinicians are not receiving any of it. The $187.48 goes to the facility operator. The operator is supposed to allocate a portion of it for clinical services. There is no SLA enforcement mechanism to verify that they do. There is only my filing cabinet, and the filing cabinet is for contracts, not outcomes. Senator Ossoff's office conducted an investigation between January and August 2025 and received 85 credible reports of medical neglect, including untreated chest pain causing heart attacks and unmanaged diabetes complications. That investigation preceded the payment freeze by two months. The conditions it documented were the baseline. The baseline was already 95% preventable death. The disbursement freeze removed the financial infrastructure supporting the 5% of care that was being provided. I have a Gantt chart in my office, printed on 11x17 cardstock and laminated and pinned above the Tums drawer, that tracks the Acentra Health onboarding timeline. The original completion date was April 30, 2026. That date passed twelve days ago. The chart has a red line through it drawn in Sharpie by my deputy, who does this for every missed milestone. There are four red lines. There will be more. Each red line represents a period during which no payment processor exists. Each period without a payment processor is a period during which clinicians must choose between providing unpaid care and not providing care. The first option costs them money. The second option costs someone their life. I do not track which choice they make. I track contracts. Seventy-one percent of ICE deaths in 2025 and 2026 occurred in privately operated detention sites. Half of 2026's deaths occurred in CoreCivic or GEO Group facilities. The Office of Detention Oversight, the COR entity responsible for facility inspections, conducted 36.25% fewer compliance audits in 2025 than the previous year. Fewer audits, more deaths, higher profits. The three trend lines move in coordinated directions. I do not draw conclusions from correlated trend lines. I am a contract administrator. I process contracts. The contracts are technically valid. The facilities are technically operational. The reimbursement apparatus is technically being replaced. The deaths are technically being counted. The word "technically" is doing more work in this paragraph than any clinician in the ICE detention system has been compensated for in seven months. My internal memo from November 12 used the phrase "absolute emergency." It recommended resolution "immediately" to "prevent any further medical complications or loss of life." That memo was written on government letterhead, classified as internal correspondence, distributed to eleven recipients, and filed in the correspondence tracking system under routing symbol HSA-OAQ, which requires a FOIA request to access. Seventeen people have died since I wrote it. The memo was technically effective. It generated a procurement action. The procurement action generated a bridge contract. The bridge contract generated an onboarding timeline. The onboarding timeline generated a Gantt chart. The Gantt chart generated four red Sharpie lines. The red Sharpie lines generated nothing. They are decorative. Like the per diem rate that includes medical care nobody is billing for. Like the 95% preventable death rate that is not being prevented. Like the word "emergency" in a seven-month-old memo that is technically still active, technically still urgent, technically still describing a situation that requires immediate resolution. I am technically still the person responsible for resolving it. The system is technically still working. The people are technically still dying. The filing cabinet is technically still organized. The contracts are technically still valid. The word "technically" has appeared so many times in this document that it has lost all meaning. That is exactly what it was designed to do.
Show more
13 years in development and this is the mission